位置:首页 > 蛋白库 > POK9_HUMAN
POK9_HUMAN
ID   POK9_HUMAN              Reviewed;        1117 AA.
AC   P63128; Q9UKH4;
DT   13-SEP-2004, integrated into UniProtKB/Swiss-Prot.
DT   23-JAN-2007, sequence version 3.
DT   03-AUG-2022, entry version 118.
DE   RecName: Full=Endogenous retrovirus group K member 9 Pol protein;
DE   AltName: Full=HERV-K(C6) Gag-Pol protein;
DE   AltName: Full=HERV-K109 Gag-Pol protein;
DE   AltName: Full=HERV-K_6q14.1 provirus ancestral Gag-Pol polyprotein;
DE   Includes:
DE     RecName: Full=Protease;
DE              EC=3.4.23.50;
DE     AltName: Full=PR;
DE     AltName: Full=Retropepsin;
DE   Includes:
DE     RecName: Full=Reverse transcriptase/ribonuclease H;
DE              EC=2.7.7.49;
DE              EC=2.7.7.7;
DE              EC=3.1.26.4;
DE     AltName: Full=p66 RT;
GN   Name=ERVK-9;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   PubMed=10469592; DOI=10.1016/s0960-9822(99)80390-x;
RA   Barbulescu M., Turner G., Seaman M.I., Deinard A.S., Kidd K.K., Lenz J.;
RT   "Many human endogenous retrovirus K (HERV-K) proviruses are unique to
RT   humans.";
RL   Curr. Biol. 9:861-868(1999).
CC   -!- FUNCTION: The products of the Gag polyproteins of infectious
CC       retroviruses perform highly complex orchestrated tasks during the
CC       assembly, budding, maturation, and infection stages of the viral
CC       replication cycle. During viral assembly, the proteins form membrane
CC       associations and self-associations that ultimately result in budding of
CC       an immature virion from the infected cell. Gag precursors also function
CC       during viral assembly to selectively bind and package two plus strands
CC       of genomic RNA. Endogenous Gag proteins may have kept, lost or modified
CC       their original function during evolution (By similarity).
CC       {ECO:0000250}.
CC   -!- FUNCTION: Early post-infection, the reverse transcriptase converts the
CC       viral RNA genome into double-stranded viral DNA. The RNase H domain of
CC       the reverse transcriptase performs two functions. It degrades the RNA
CC       template and specifically removes the RNA primer from the RNA/DNA
CC       hybrid. Following nuclear import, the integrase catalyzes the insertion
CC       of the linear, double-stranded viral DNA into the host cell chromosome.
CC       Endogenous Pol proteins may have kept, lost or modified their original
CC       function during evolution (By similarity). {ECO:0000250}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=Processing at the authentic HIV-1 PR recognition site and
CC         release of the mature p17 matrix and the p24 capsid protein, as a
CC         result of the cleavage of the -SQNY-|-PIVQ- cleavage site.;
CC         EC=3.4.23.50;
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=a 2'-deoxyribonucleoside 5'-triphosphate + DNA(n) =
CC         diphosphate + DNA(n+1); Xref=Rhea:RHEA:22508, Rhea:RHEA-COMP:17339,
CC         Rhea:RHEA-COMP:17340, ChEBI:CHEBI:33019, ChEBI:CHEBI:61560,
CC         ChEBI:CHEBI:173112; EC=2.7.7.49; Evidence={ECO:0000255|PROSITE-
CC         ProRule:PRU00405};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=a 2'-deoxyribonucleoside 5'-triphosphate + DNA(n) =
CC         diphosphate + DNA(n+1); Xref=Rhea:RHEA:22508, Rhea:RHEA-COMP:17339,
CC         Rhea:RHEA-COMP:17340, ChEBI:CHEBI:33019, ChEBI:CHEBI:61560,
CC         ChEBI:CHEBI:173112; EC=2.7.7.7; Evidence={ECO:0000255|PROSITE-
CC         ProRule:PRU00405};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=Endonucleolytic cleavage to 5'-phosphomonoester.; EC=3.1.26.4;
CC   -!- SUBCELLULAR LOCATION: Cell membrane. Note=Cytoplasmic membrane (in a
CC       transfection system). {ECO:0000250}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Ribosomal frameshifting; Named isoforms=2;
CC         Comment=This protein is synthesized as a Gag polypeptide and as a
CC         Gag-Pro-Pol polyprotein. The later is the precursor of the Pro and
CC         Pol proteins. It is thought, by similarity with type-B retroviruses,
CC         to be generated by -1 frameshifts occurring at the Gag-Pro and
CC         Pro-Pol genes boundaries.;
CC       Name=1;
CC         IsoId=P63128-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=P63126-1; Sequence=External;
CC   -!- DOMAIN: The LPQG motifs are catalytically important and conserved among
CC       many retroviruses.
CC   -!- DOMAIN: HERV-K Gag polyprotein contains regions homologous to the
CC       matrix (MA), capsid (CA) and nucleocapsid (NC) proteins from infectious
CC       retroviruses. Evidence suggests that HERV-K(HML-2) Gag polyprotein can
CC       be cleaved into mature MA, CA and NC under certain circumstances.
CC       However, the exact boundaries as well as the size of processed Gag
CC       proteins have not been precisely determined yet.
CC   -!- PTM: Myristoylation is essential for retroviral assembly. Alteration of
CC       the glycine residue leads to a block in the budding of particles and an
CC       accumulation of Gag inside the cell (By similarity). {ECO:0000250}.
CC   -!- PTM: Specific enzymatic cleavages may yield mature proteins.
CC       {ECO:0000305}.
CC   -!- SIMILARITY: Belongs to the beta type-B retroviral polymerase family.
CC       HERV class-II K(HML-2) pol subfamily. {ECO:0000305}.
CC   -!- CAUTION: Truncated; frameshift leads to premature stop codon.
CC       {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AF164615; AAD51799.1; ALT_SEQ; Genomic_DNA.
DR   PDB; 6SA9; X-ray; 1.80 A; A/B=282-433.
DR   PDBsum; 6SA9; -.
DR   AlphaFoldDB; P63128; -.
DR   SMR; P63128; -.
DR   IntAct; P63128; 1.
DR   iPTMnet; P63128; -.
DR   PhosphoSitePlus; P63128; -.
DR   BioMuta; HGNC:39005; -.
DR   DMDM; 118572691; -.
DR   jPOST; P63128; -.
DR   MassIVE; P63128; -.
DR   PeptideAtlas; P63128; -.
DR   PRIDE; P63128; -.
DR   GeneCards; ERVK-9; -.
DR   HGNC; HGNC:39005; ERVK-9.
DR   neXtProt; NX_P63128; -.
DR   PhylomeDB; P63128; -.
DR   Pharos; P63128; Tdark.
DR   Proteomes; UP000005640; Unplaced.
DR   RNAct; P63128; protein.
DR   GO; GO:0005886; C:plasma membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0004190; F:aspartic-type endopeptidase activity; IEA:InterPro.
DR   GO; GO:0003887; F:DNA-directed DNA polymerase activity; IEA:UniProtKB-EC.
DR   GO; GO:0003723; F:RNA binding; IEA:UniProtKB-KW.
DR   GO; GO:0003964; F:RNA-directed DNA polymerase activity; IEA:UniProtKB-KW.
DR   GO; GO:0004523; F:RNA-DNA hybrid ribonuclease activity; IEA:UniProtKB-EC.
DR   GO; GO:0005198; F:structural molecule activity; IEA:InterPro.
DR   GO; GO:0008270; F:zinc ion binding; IEA:InterPro.
DR   GO; GO:0006508; P:proteolysis; IEA:UniProtKB-KW.
DR   GO; GO:0016032; P:viral process; IEA:InterPro.
DR   CDD; cd05482; HIV_retropepsin_like; 1.
DR   CDD; cd07557; trimeric_dUTPase; 1.
DR   Gene3D; 1.10.1200.30; -; 1.
DR   Gene3D; 1.10.150.490; -; 1.
DR   Gene3D; 1.10.375.10; -; 1.
DR   Gene3D; 2.40.70.10; -; 1.
DR   Gene3D; 2.70.40.10; -; 1.
DR   Gene3D; 3.30.70.270; -; 1.
DR   InterPro; IPR001969; Aspartic_peptidase_AS.
DR   InterPro; IPR003322; B_retro_matrix.
DR   InterPro; IPR038124; B_retro_matrix_sf.
DR   InterPro; IPR043502; DNA/RNA_pol_sf.
DR   InterPro; IPR029054; dUTPase-like.
DR   InterPro; IPR036157; dUTPase-like_sf.
DR   InterPro; IPR033704; dUTPase_trimeric.
DR   InterPro; IPR000467; G_patch_dom.
DR   InterPro; IPR045345; Gag_p24_C.
DR   InterPro; IPR000721; Gag_p24_N.
DR   InterPro; IPR001995; Peptidase_A2_cat.
DR   InterPro; IPR021109; Peptidase_aspartic_dom_sf.
DR   InterPro; IPR034170; Retropepsin-like_cat_dom.
DR   InterPro; IPR018061; Retropepsins.
DR   InterPro; IPR008916; Retrov_capsid_C.
DR   InterPro; IPR008919; Retrov_capsid_N.
DR   InterPro; IPR010999; Retrovr_matrix.
DR   InterPro; IPR043128; Rev_trsase/Diguanyl_cyclase.
DR   InterPro; IPR000477; RT_dom.
DR   InterPro; IPR001878; Znf_CCHC.
DR   InterPro; IPR036875; Znf_CCHC_sf.
DR   Pfam; PF00692; dUTPase; 1.
DR   Pfam; PF01585; G-patch; 1.
DR   Pfam; PF02337; Gag_p10; 1.
DR   Pfam; PF00607; Gag_p24; 1.
DR   Pfam; PF19317; Gag_p24_C; 1.
DR   Pfam; PF00077; RVP; 1.
DR   Pfam; PF00078; RVT_1; 1.
DR   Pfam; PF00098; zf-CCHC; 1.
DR   SMART; SM00443; G_patch; 1.
DR   SMART; SM00343; ZnF_C2HC; 2.
DR   SUPFAM; SSF47836; SSF47836; 1.
DR   SUPFAM; SSF47943; SSF47943; 1.
DR   SUPFAM; SSF50630; SSF50630; 1.
DR   SUPFAM; SSF51283; SSF51283; 1.
DR   SUPFAM; SSF56672; SSF56672; 1.
DR   SUPFAM; SSF57756; SSF57756; 2.
DR   PROSITE; PS50175; ASP_PROT_RETROV; 1.
DR   PROSITE; PS00141; ASP_PROTEASE; 1.
DR   PROSITE; PS50174; G_PATCH; 1.
DR   PROSITE; PS50878; RT_POL; 1.
DR   PROSITE; PS50158; ZF_CCHC; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Cell membrane; ERV; Hydrolase; Lipoprotein; Membrane;
KW   Metal-binding; Multifunctional enzyme; Myristate; Nucleotidyltransferase;
KW   Protease; Reference proteome; Repeat; Ribosomal frameshifting; RNA-binding;
KW   RNA-directed DNA polymerase; Transferase; Transposable element; Zinc;
KW   Zinc-finger.
FT   INIT_MET        1
FT                   /note="Removed"
FT                   /evidence="ECO:0000255"
FT   CHAIN           2..1117
FT                   /note="Endogenous retrovirus group K member 9 Pol protein"
FT                   /id="PRO_0000186764"
FT   DOMAIN          58..195
FT                   /note="Reverse transcriptase"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00405"
FT   DOMAIN          800..875
FT                   /note="Peptidase A2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00275"
FT   DOMAIN          890..936
FT                   /note="G-patch"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00092"
FT   ZN_FING         544..561
FT                   /note="CCHC-type 1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00047"
FT   ZN_FING         580..597
FT                   /note="CCHC-type 2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00047"
FT   REGION          165..264
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          598..629
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        187..205
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        217..253
FT                   /note="Pro residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   ACT_SITE        805
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU10094"
FT   LIPID           2
FT                   /note="N-myristoyl glycine"
FT                   /evidence="ECO:0000255"
FT   STRAND          284..286
FT                   /evidence="ECO:0007829|PDB:6SA9"
FT   HELIX           312..325
FT                   /evidence="ECO:0007829|PDB:6SA9"
FT   HELIX           330..342
FT                   /evidence="ECO:0007829|PDB:6SA9"
FT   HELIX           347..357
FT                   /evidence="ECO:0007829|PDB:6SA9"
FT   HELIX           360..383
FT                   /evidence="ECO:0007829|PDB:6SA9"
FT   STRAND          384..386
FT                   /evidence="ECO:0007829|PDB:6SA9"
FT   HELIX           392..396
FT                   /evidence="ECO:0007829|PDB:6SA9"
FT   HELIX           399..402
FT                   /evidence="ECO:0007829|PDB:6SA9"
FT   HELIX           405..408
FT                   /evidence="ECO:0007829|PDB:6SA9"
FT   HELIX           413..428
FT                   /evidence="ECO:0007829|PDB:6SA9"
SQ   SEQUENCE   1117 AA;  123620 MW;  F7614F482B4117DD CRC64;
     MGQTKSKIKS KYASYLSFIK ILLKRGGVKV STKNLIKLFQ IIEQFCPWFP EQGTLDLKDW
     KRIGKELKQA GRKGNIIPLT VWNDWAIIKA ALEPFQTEED SISVSDAPGS GIIDCNEKTR
     KKSQKETESL HCEYVAEPVM AQSTQNVDYN QLQEVIYPET LKLEGKGPEL VGPSESKPRG
     TSPLPAGQVP VTLQPQKQVK ENKTQPPVAY QYWPPAELQY RPPPESQYGY PGMPPAPQGR
     APYPQPPTRR LNPTAPPSRQ GSELHEIIDK SRKEGDTEAW QFPVTLEPMP PGEGAQEGEP
     PTVEARYKSF SIKILKDMKE GVKQYGPNSP YMRTLLDSIA HGHRLIPYDW EILAKSSLSP
     SQFLQFKTWW IDGVQEQVRR NRAANPPVNI DADQLLGIGQ NWSTISQQAL MQNEAIEQVR
     AICLRAWEKI QDPGSTCPSF NTVRQGSKEP YPDFVARLQD VAQKSIADEK ARKVIVELMA
     YENANPECQS AIKPLKGKVP AGSDVISEYV KACDGIGGAM HKAMLMAQAI TGVVLGGQVR
     TFGGKCYNCG QIGHLKKNCP VLNKQNITIQ ATTTGREPPD LCPRCKKGKH WASQCRSKFD
     KNGQPLSGNE QRGQPQAPQQ TGAFPIQPFV PQGFQGQQPP LSQVFQGISQ LPQYNNCPPP
     QVAVQQVDLC TIQAVSLLPG EPPQKIPTGV YGPLPEGTVG LILGRSSLNL KGVQIHTSVV
     DSDYKGEIQL VISSSVPWSA SPGDRIAQLL LLPYIKGGNS EIKRIGGLGS TDPTGKAAYW
     ASQVSENRPV CKAIIQGKQF EGLVDTGADV SIIALNQWPK NWPKQKAVTG LVGIGTASEV
     YQSMEILHCL GPDNQESTVQ PMITSIPLNL WGRDLLQQWG AEITMPAPLY SPTSQKIMTK
     RGYIPGKGLG KNEDGIKIPF EAKINQKREG IGYPFLGAAT IEPPKPIPLT WKTEKPVWVN
     QWPLPKQKLE ALHLLANEQL EKGHIEPSFS PWNSPVFVIQ KKSGKWRMLT DLRAVNAVIQ
     PMGPLQPGLP SPAMIPKDWP LIIIDLKDCF FTIPLAEQDC EKFAFTIPAI NNKEPATRFQ
     WKVLPQGMLN SPTICQTFVG RALQPVKVFR LLYYSLY
 
 
维奥蛋白资源库 - 中文蛋白资源 CopyRight © 2010-2024